Neoplastic bone marrow niche: Hematopoietic and mesenchymal stem cells

Cell Journal

Volumn 13, Issue 3, 2011, Pages 131-136

  Saki, Najmaldin ^a,b   Abroun, Saeid ^a   Hagh, Majid Farshdousti ^c   Asgharei, Farahnaz ^d  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d Rostok University   (Germany)

Author keywords

Bone marrow; Cancer; Neoplastic niche; Stem cells

Indexed keywords

5' NUCLEOTIDASE; ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; ADAPALENE; ALPHA SMOOTH MUSCLE ACTIN; ALPHA5 INTEGRIN; BETA1 INTEGRIN; CD123 ANTIGEN; CD44V ANTIGEN; CD71 ANTIGEN; CD9 ANTIGEN; DECAY ACCELERATING FACTOR; ENDOGLIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 4 RECEPTOR ALPHA; INTERLEUKIN 6 RECEPTOR; INTERLEUKIN 7 RECEPTOR; MICROSOMAL AMINOPEPTIDASE; NOTCH RECEPTOR; OSTEOCLAST DIFFERENTIATION FACTOR; REACTIVE OXYGEN METABOLITE; THY 1 ANTIGEN; TUMOR NECROSIS FACTOR; VASCULOTROPIN;

CANCER STEM CELL; CELL MIGRATION; CELL RENEWAL; CLONOGENESIS; HEMATOPOIETIC STEM CELL; INTRACELLULAR SIGNALING; MESENCHYMAL STEM CELL; MICROENVIRONMENT; MOLECULAR INTERACTION; OSTEOBLAST; OSTEOCLAST; REVIEW; STEM CELL NICHE;

EID: 83455205837     PISSN: 22285806     EISSN: 22285814     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Abroun S, Saki N. Cellular and molecular aspects of multiple myeloma. Sci J Blood Transfus Organ. 2010; 7(3): 183-195.
2. Yin T, Li L. The stem cell niches in bone. J Clin Invest. 2006; 116(5): 1195-1201.
3. Saki N, Abroun S, Soleymani M, Kaviani S, Sadeghi B,Vaghef N. The role of myeloma cells in the in -vitro differentiation of cord blood hematopoietic stem cell to osteoclast. Modares Journal of Medical Sciences: Pathobiology. 2010; 13(3): 53-61.
4. Frisch BJ, Porter RL, Calvi LM. Hematopoietic niche and bone meet. Curr Opin Support Palliat Care. 2008; 2(3): 211-217.
5. Abroun S. Chemokines in hemostasis and cancers. Yakhteh. 2008; 10(39): 155-166
6. Sadeghi B, Abroun S, Poupak B,Hajfathali A, Saki N, Vaghef N. The role of myeloma cells to osteoclast activation. Cell Journal (Yakhteh). 2010; 12(3): 357-366.
7. Chamberlain G, Fox J, Ashton B, Middleton J. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells. 2007; 25(11): 2739-2749. (Pubitemid 350127858)
8. Westerweel PE, Verhaar MC. Directing myogenic mesenchymal stem cell differentiation. Circ Res. 2008; 103(6): 560-561.
9. Nadri S, Soleimani M, Mobarra Z, Amini S. Expression of dopamine-associated genes on conjunctiva stromal-derived human mesenchymal stem cells. Biochem Biophys Res Commun. 2008; 377(2): 423-428.
10. Jazayeri M, Allameh A, Soleimani M, Jazayeri SH, Piryaei A, Kazemnejad S. Molecular and ultrastructural characterization of endothelial cells differentiated from human bone marrow mesenchymal stem cells. Cell Biol Int. 2008; 32(10): 1183-1192.
11. Gang EJ, Bosnakovski D, Figueiredo CA, Visser JW, Perlingeiro RC. SSEA-4 identifies mesenchymal stem cells from bone marrow. Blood. 2007; 109(4): 1743-1751. (Pubitemid 46239610)
12. Lin G, Liu G, Banie L, Wang G, Ning H, Lue TF, et al. Tissue Distribution of Mesenchymal Stem Cell Marker Stro-1. Stem Cells Dev. 2011; 20(10): 1747-1752.
13. Nauta AJ, Fibbe WE. Immunomodulatory properties of mesenchymal stromal cells. Blood. 2007; 110(10): 3499-3506. (Pubitemid 350159613)
14. Zhang L, Chan C. Isolation and enrichment of rat mesenchymal stem cells (MSCs) and separation of singlecolony derived MSCs. J Vis Exp. 2010; 37: pii: 1852. Doi: 10.3791/1852.
15. Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem. 2006; 98(5): 1076-1084. (Pubitemid 44128350)
16. Meirelles Lda S, Fontes AM, Covas DT, Caplan AI. Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev. 2009; 20(5-6): 419-427.
17. Jazayeri M, Allameh A,Soleimani M, Jazayeri SH, Kaviani S, Kazemnejad S. Capillary network formation by endothelial cells differentiated from human bone marrow mesenchymal stem cells. Iranian Journal of Biotechnology(IJB). 2008; 6(1): 29-35.
18. Nassiri SM, Khaki Z, Soleimani M, Ahmadi SH, Jahanzad I, Rabbani S, et al. The similar effect of transplantation of marrow-derived mesenchymal stem cells with or without prior differentiation induction in experimental myocardial infarction. J Biomed Sci. 2007; 14(6): 745-755. (Pubitemid 47573152)
19. Bielby R, Jones E, McGonagle D. The role of mesenchymal stem cells in maintenance and repair of bone. Injury. 2007; 38(1): 26-32.
20. Vukicevic S, Grgurevic L. BMP-6 and mesenchymal stem cell differentiation. Cytokine Growth Factor Rev. 2009; 20(5-6): 441-448.
21. Zhang W, Deng ZL, Chen L, Zuo GW, Luo Q, Shi Q, et al. Retinoic acids potentiate BMP9-induced osteogenic differentiation of mesenchymal progenitor cells. PLoS One. 2010; 5(7): e11917.
22. Miraoui H, Marie PJ. Fibroblast growth factor receptor signaling crosstalk in skeletogenesis. Sci Signal. 2010; 3(146): re9.
23. Dimitriou R, Tsiridis E, Giannoudis PV. Current concepts of molecular aspects of bone healing. Injury. 2005; 36(12): 1392-1404. (Pubitemid 41618169)
24. Delalat B, Pourfathollah AA, Soleimani M, Mozdarani H, Ghaemi SR, Movassaghpour AA, et al. Isolation and ex vivo expansion of human umbilical cord blood-derived-CD34+ stem cells and their cotransplantation with or without mesenchymal stem cells. Hematology. 2009; 14(3): 125-132.
25. Qiao L, Xu ZL, Zhao TJ, Ye LH, Zhang XD. Dkk-1 secreted by mesenchymal stem cells inhibits growth of breast cancer cells via depression of Wnt signalling. Cancer Lett. 2008; 269(1): 67-77.
26. Zanotti S, Canalis E. Notch and the skeleton. Mol Cell Biol. 2010; 30(4): 886-896.
27. Valenti MT, Dalle Carbonare L, Donatelli L, Bertoldo F, Zanatta M,et al. Gene expression analysis in osteoblastic differentiation from peripheral blood mesenchymal stem cells. Bone. 2008; 43(6): 1084-1092.
28. Ambrosetti D, Holmes G, Mansukhani A, Basilico C. Fibroblast growth factor signaling uses multiple mechanisms to inhibit Wnt-induced transcription in osteoblasts. Mol Cell Biol. 2008; 28(15): 4759-4771.
29. Mansukhani A, Ambrosetti D, Holmes G, Cornivelli L, Basilico C. Sox2 induction by FGF and FGFR2 activating mutations inhibits Wnt signaling and osteoblast differentiation. J Cell Biol. 2005; 168(7): 1065-1076.
30. Xia H, Cheung WK, Sze J, Lu G, Jiang S, Yao H, et al. miR-200a regulates epithelial-mesenchymal to stem-like transition via ZEB2 and beta-catenin signaling. J Biol Chem. 2010; 285(47): 36995-37004.
31. Kim HS, Shin TH, YangSR, Seo MS, Kim DJ, Kang SK, et al. Implication of NOD1 and NOD2 for the differentiation of multipotent mesenchymal stem cells derived from human umbilical cord blood. PLoS One. 2010; 5(10): e15369.
32. Takada I, Kouzmenko AP, Kato S. PPAR-gamma Signaling Crosstalk in Mesenchymal Stem Cells. PPAR Res. 2010: doi: 10.1155/2010/341671.
33. Pountos I, Corscadden D, Emery P, Giannoudis PV. Mesenchymal stem cell tissue engineering: techniques for isolation, expansion and application. Injury. 2007; 38Suppl 4: S23-33. (Pubitemid 351162869)
34. Bickenbach JR. Isolation, characterization, and culture of epithelial stem cells. Methods Mol Biol. 2005; 289: 97-102.
35. Kestendjieva S, Kyurkchiev D, Tsvetkova G, Mehandjiev T, Dimitrov A, Nikolov A, et al. Characterization of mesenchymal stem cells isolated from the human umbilical cord. Cell Biol Int. 2008; 32(7): 724-732.
36. Ponzoni M, Arrigoni G, Gould VE, Del Curto B, Maggioni M, Scapinello A, et al. Lack of CD 29 (beta1 integrin) and CD 54 (ICAM-1) adhesion molecules in intravascular lymphomatosis. Hum Pathol. 2000; 31(2): 220-226. (Pubitemid 30090652)
37. Mahlknecht U, Schonbein C. Histone deacetylase inhibitor treatment downregulates VLA-4 adhesion in hematopoietic stem cells and acute myeloid leukemia blast cells. Haematologica. 2008; 93(3): 443-446. (Pubitemid 351398647)
38. Boisvert M, Chetoui N, GendronS, Aoudjit F. Alpha2beta1 integrin is the major collagen-binding integrin expressed on human Th17 cells. Eur J Immunol. 2010; 40(10): 2710-2719.
39. Kuci S, Kuci Z, Kreyenberg H, Deak E, Putsch K, Huenecke S, et al. CD271 antigen defines a subset of multipotent stromal cells with immunosuppressive and lymphohematopoietic engraftment-promoting properties. Haematologica. 2010; 95(4): 651-659.
40. Tarnok A, Ulrich H, Bocsi J. Phenotypes of stem cells from diverse origin. Cytometry A. 2010; 77(1): 6-10.
41. Larochelle A, Savona M, Wiggins M, Anderson S, Ichwan B, Keyvanfar K, et al. Human and rhesus macaque hematopoietic stem cells cannot be purified based only on SLAM family markers. Blood. 2011; 117(5): 1550-1554.
42. Bethel M, Srour EF, Kacena MA. Hematopoietic cell regulation of osteoblast proliferation and differentiation. Curr Osteoporos Rep. 2011; 9(2): 96-102.
43. Lymperi S, Ersek A, Ferraro F, Dazzi F, Horwood NJ. Inhibition of osteoclast function reduces hematopoietic stem cell numbers in vivo. Blood. 2011; 117(5): 1540-1549.
44. Bramono DS, Rider DA, Murali S, Nurcombe V, Cool SM. The effect of human bone marrow stroma-derived heparan sulfate on the ex vivo expansion of human cord blood hematopoietic stem cells. Pharm Res.2011; 28(6): 1385-1394.
45. Radtke F, Wilson A, Mancini SJ, MacDonald HR. Notch regulation of lymphocyte development and function. Nat Immunol. 2004; 5(3): 247-253. (Pubitemid 38332121)
46. Stier S, Cheng T, Dombkowski D, Carlesso N, Scadden DT. Notch1 activation increases hematopoietic stem cell self-renewal in vivo and favors lymphoid over myeloid lineage outcome. Blood. 2002; 99(7): 2369-2378. (Pubitemid 34525422)
47. Zhang J, Niu C, Ye L, Huang H, He X, Tong WG, et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature. 2003; 425(6960); 836-841. (Pubitemid 37351467)
48. Calvi LM, Adams GB, Weibrecht KW, Weber JM, Olson DP, Knight MC, et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature. 2003; 425(6960): 841-846. (Pubitemid 37351468)
49. Mancini SJ, Mantei N, Dumortier A, Suter U, MacDonald HR, Radtke F. Jagged1-dependent Notch signaling is dispensable for hematopoietic stem cell self-renewal and differentiation. Blood. 2005; 105(6): 2340-2342. (Pubitemid 40387028)
50. Dazzi F, Ramasamy R, Glennie S, Jones SP, Roberts I. The role of mesenchymal stem cells in haemopoiesis. Blood Rev. 2006; 20(3): 161-171.
51. Roodman GD. Regulation of osteoclast differentiation. Ann N Y Acad Sci. 2006; 1068: 100-109. (Pubitemid 43824141)
52. Arai F, Hirao A, Ohmura M, Sato H, Matsuoka S, Takubo K, et al. Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell. 2004; 118(2): 149-161. (Pubitemid 38962572)
53. Kiel MJ, Radice GL, Morrison SJ. Lack of evidence that hematopoietic stem cells depend on N-cadherin-mediated adhesion to osteoblasts for their maintenance. Cell Stem-Cell. 2007; 1(2): 204-217. (Pubitemid 47215590)
54. Hosokawa K, Arai F, Yoshihara H, Nakamura Y, Gomei Y, Iwasaki H, et al. Function of oxidative stress in the regulation of hematopoietic stem cell-niche interaction. Biochem Biophys Res Commun. 2007; 363(3): 578-583. (Pubitemid 47513670)
55. Udagawa N, Takahashi N, Jimi E, Matsuzaki K, Tsurukai T, Itoh K, et al. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand. Bone. 1999; 25(5): 517-523. (Pubitemid 29469457)
56. Teitelbaum SL. Bone resorption by osteoclasts. Science. 2000; 289(5484): 1504-1508.
57. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, et al. Osteoprotegerin: a novel secretedprotein involved in the regulation of bone density. Cell. 1997; 89(2): 309-319. (Pubitemid 27199902)
58. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 1998; 93(2): 165-176. (Pubitemid 28180851)
59. Lymperi S, Horwood N, Marley S, Gordon MY, Cope AP, Dazzi F. Strontium can increase some osteoblasts without increasing hematopoietic stem cells. Blood. 2008; 111(3): 1173-1181. (Pubitemid 351213398)
60. Li L, Neaves WB. Normal stem cells andcancer stem cells: the niche matters. Cancer Res. 2006; 66(9): 4553-4557.
61. Haramis AP, Begthel H, van den Born M, van Es J, Jonkheer S, Offerhaus GJ, et al. De novo crypt formation and juvenile polyposis on BMP inhibition in mouse intestine. Science. 2004 12; 303(5664): 1684-1686.
62. He XC, Zhang J, Tong WG, Tawfik O, Ross J, Scoville DH, et al. BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-beta-catenin signaling. Nat Genet. 2004; 36(10): 1117-1121. (Pubitemid 41184475)
63. Jamieson CH, Ailles LE, Dylla SJ, Muijtjens M, Jones C, Zehnder JL, et al. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N Engl J Med. 2004; 351(7): 657-667. (Pubitemid 39063268)
64. Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Costa C, et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature. 2005; 438(7069): 820-827. (Pubitemid 41753060)
65. Vaghef N, Abroun S, Kaviani S, Alimoghadam K, Rostami S, Sadeghi B, et al. The role of Leptin in pathophysiology of myeloma cells. Cell Journal (Yakhteh). 2010; 12(3): 319-328.